Tumour derived extracellular vesicles: challenging target to blunt tumour immune evasion

HIGHLIGHTS

  • who: Tatiana Lopatina et al. from the Department of Medical Sciences, Turin University, Turin, Italy have published the research: Tumour Derived Extracellular Vesicles: Challenging Target to Blunt Tumour Immune Evasion, in the Journal: Cancers 2022, 14, 4020. of /2022/
  • what: Early after EV discovery [294] it was reported that cancer cells release TEV enriched in proteins and lipids, contributing to tumour immune escape [295].
  • future: Studies are required to clarify this specific topic.

SUMMARY

    It was shown that TEV are primarily internalised by APC, thereby suggesting that TEV regulate . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?